EMBECTA CORP. Other Noncash Income (Expense)
EMBECTA CORP. (EMBC) reported Other Noncash Income (Expense) of -$7.70 million for the 9-month period ending 2022-06-30, per its 10-Q filed 2022-08-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2022-08-15
- EMBECTA CORP. other noncash income (expense) for the quarter ending 2022-06-30 was -$7.30M.
- EMBECTA CORP. other noncash income (expense) for the quarter ending 2021-06-30 was $0.00.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 6 month | Other Noncash Income (Expense) 9 month |
|---|---|---|---|
| 2022-06-30 | -$7.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-15 | -$7.70M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | -$400.00K 10-Q · filed 2022-05-13 | ||
| 2021-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-15 | -$200.00K 10-Q · filed 2022-08-15 | |
| 2021-03-31 | -$200.00K 10-Q · filed 2022-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |